Inbrija

Indicated For

Parkinson's disease OFF episodes

About This Medication

# Merz Patient Assistance Program Patient Guide: How to Get Inbrija (levodopa) at Low or No Cost Inbrija (levodopa) is an inhaled powder prescription medication used to treat **off episodes** in adults with Parkinson's disease who are already taking levodopa/carbidopa medications. The **Merz Patient Assistance Program** provides Inbrija at no cost to eligible patients who cannot afford their prescription due to financial hardship or insurance gaps. ## About Inbrija (levodopa) **Inbrija** is a fast-acting treatment specifically designed for sudden 'off' periods when Parkinson's symptoms like tremors, stiffness, or slowness return despite regular oral levodopa therapy. Administered via a handheld inhaler, it delivers levodopa directly to the lungs for quick absorption into the bloodstream, often providing symptom relief within 10 minutes. It's FDA-approved for use up to four times daily during off episodes, as needed, and does not replace your regular Parkinson's medications. Common side effects include cough, upper respiratory tract infection, headache, and nausea. Serious risks can include lung problems (like bronchospasm) or dyskinesia (uncontrolled movements). Always use under your doctor's guidance, and inform them if you have asthma, COPD, or lung issues, as Inbrija is not recommended for those with moderate-to-severe lung disease. This program helps ensure access to this important therapy when costs are a barrier. Merz North America, the manufacturer, runs the program to support patients facing financial challenges.[1] ## Who Qualifies for the Program? The Merz Patient Assistance Program is for **U.S. residents** (including Puerto Rico and other territories) who: - Cannot afford their Inbrija prescription due to lack of insurance or high out-of-pocket costs. - Meet financial need criteria, typically based on household income relative to the Federal Poverty Level (FPL). - Are not enrolled in government programs like Medicare, Medicaid, or other federal/state-funded healthcare. Eligibility is determined case-by-case by calling the program, as specific income thresholds are not publicly detailed online. Programs like this often target incomes at or below 400-500% of the FPL, but you must verify by phone.[1][6] ## Income Eligibility Breakdown Exact income limits for Inbrija are confirmed via phone application, but similar Merz programs (e.g., for Xeomin) use Federal Poverty Guidelines (FPL) with proof of income required. Here's a general table based on 2026 FPL estimates for the contiguous U.S. (Hawaii/Alaska are higher; actual eligibility may vary): | Household Size | 400% FPL (Example Threshold) | 500% FPL (Possible Upper Limit) | |----------------|------------------------------|---------------------------------| | 1 person | ~$60,240 | ~$75,300 | | 2 people | ~$81,760 | ~$102,200 | | 3 people | ~$103,280 | ~$129,100 | | 4 people | ~$124,800 | ~$156,000 | *Notes: Add ~$21,520 per additional person for 400% FPL. Provide proof like tax returns, W-2s, or pay stubs. Call (833) 462-7452 to confirm your situation. Eligibility isn't guaranteed and may change.*[1][6] ## Insurance Requirements This program targets patients who **cannot afford their Inbrija prescription**, including: - Uninsured individuals. - Underinsured patients with commercial insurance but high copays/deductibles. You **cannot** be on Medicare, Medicaid, VA benefits, or other government programs. If underinsured, your doctor may need to confirm prior authorization steps or coverage denials before free medication is provided. Report any insurance changes within 30 days, as they can affect eligibility.[1][6] ## Step-by-Step Application Process 1. **Contact the Program**: Call **(833) 462-7452** Monday-Friday during business hours (similar programs operate 8am-7pm ET). Discuss your situation; staff will guide eligibility and next steps.[program details] 2. **Gather Documents**: Prepare proof of income (e.g., last year's tax return, W-2, 1099, pay stubs), insurance details (policy ID, group number), and patient info (DOB, address, doctor's contact).[1] 3. **Complete Enrollment**: Use the phone process or download forms if available (check merzconnect.com). Include prescriber details; your doctor may need to sign or verify medical need.[1] 4. **Submit**: Fax or mail as instructed (e.g., similar programs use fax 1-855-825-0488). Authorize release of health/insurance info for verification.[1] 5. **Await Approval**: Expect notification soon after submission. If approved, medication ships directly to your doctor or pharmacy.[1][8] ## Timeline and Delivery Processing varies but similar Merz programs notify within 5 business days via fax/email. Once approved, Inbrija ships free to your prescriber's office or designated pharmacy for pickup. Refills follow the same eligibility check; re-enroll annually. Track status by calling the support line.[1][8] ## Alternatives if Denied or Ineligible - **Merz Connect Savings Card**: For commercially insured patients, check merzconnect.com for copay assistance up to $5,000/year (restrictions apply, e.g., no government insurance).[6] - **Other PAPs**: NeedyMeds.org or RxAssist.org list Parkinson's programs like AbbVie or Acadia for levodopa alternatives. - **State Programs**: Contact your state health department for generic levodopa assistance. - **Doctor's Help**: Ask about patient access programs, samples, or switching to affordable generics. - **Non-Profits**: PAN Foundation or HealthWell Foundation may cover Parkinson's copays. ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Program details can change; **always verify directly with Merz at (833) 462-7452**. Eligibility isn't guaranteed, and assistance may end anytime. Consult your doctor before starting Inbrija. Merz reserves rights to modify terms. Not legal/medical advice.

Program information last verified: March 30, 2026